CLPT
Clearpoint Neuro IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$332.25M
P/E Ratio
—
EPS
$-0.90
Beta
1.18
52W High
$30.10
52W Low
$8.27
50-Day MA
$10.81
200-Day MA
$14.06
Dividend Yield
—
Profit Margin
-69.10%
Forward P/E
12.11
PEG Ratio
0.60
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $36.97M |
| Gross Profit (TTM) | $22.69M |
| EBITDA | $-21.48M |
| Operating Margin | -50.40% |
| Return on Equity | -95.60% |
| Return on Assets | -20.40% |
| Revenue/Share (TTM) | $1.31 |
| Book Value | $0.95 |
| Price-to-Book | 12.00 |
| Price-to-Sales (TTM) | 8.99 |
| EV/Revenue | 9.43 |
| EV/EBITDA | -7.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 34.00% |
| Shares Outstanding | $29.99M |
| Float | $25.33M |
| % Insiders | 8.25% |
| % Institutions | 51.00% |
Historical Volatility
HV 10-Day
98.87%
HV 20-Day
88.64%
HV 30-Day
90.11%
HV 60-Day
102.40%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($25.00 target)
2
BuyData last updated: 4/29/2026